Amanda Olson

Associate Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Amanda Olson is an Associate Professor at the University of Texas MD Anderson Cancer Center in the United States. Her research focuses on hematologic malignancies, particularly in the context of stem cell transplantation, graft-versus-host disease, and prognostic factors influencing patient outcomes. Recent publications include studies on the prognosis of acute graft-vs.-host disease and the long-term effects of haploidentical stem cell transplantation.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Portia Smallbone

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Oren Pasvolsky

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Qaiser Bashir

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Sajad Khazal

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Gheath Alatrash

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jeremy Ramdial

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amanda Olson

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies

Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease

Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis

Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation

Myeloablative Fractionated Busulfan for Allogeneic Stem Cell Transplant in Older Patients or Patients with Comorbidities

Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission

Decrease post-transplant relapse using donor-derived expanded NK-cells

Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality

Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

Collaborators (6)

Portia Smallbone

Oren Pasvolsky

Qaiser Bashir

Sajad Khazal

Gheath Alatrash

Jeremy Ramdial

Make your next move.